oral medication glp 1 Semaglutide Gets FDA Approval for CV Event Reduction in High-risk Diabetes Patients glp 1 oral medication Wegovy
Description
GLP-1 (Glucagon like peptide-1 receptor agonists)
EP163 GLP-1 GLP-1RAs GLP-1RAs GLP-1GLP-1RAs semaglutideliraglutide GLP-1RAs #GLP1 #GLP1RAs # # # # # # #tirzepatide #semaglutide Dr
The Risks: Unknown ingredients and contamination Incorrect dosages and life-threatening side effects No regulatory oversight or safety data Why This Is Critical: Patients are bypassing pharmacies and getting injections from sketchy online vendors This undermines real GLP1 therapies and can lead to serious harm As healthcare professionals, we must: Ask patients about the source of their medications Report adverse reactions to MedWatch Educate our patients about safe access and real prescriptions Lets advocate for ethical prescribing and responsible patient care in the GLP1 era
Hunger GLP-1** is a patented, Health Canada-approved dietary supplement that provides satiety and sweetness
Novo Nordisks semaglutide will soon be available in a daily pill Americans can take for weight loss.
Contact our team today.
